Article
Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Breast cancer research and treatment - 1 Sept 2010
Qi Xiaowei, Ma Xiangyu, Yang Xinhua, Fan Linjun, Zhang Yi, Zhang Fan, Chen Li, Zhou Yan, Jiang Jun
Abstract excerpt
The association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and breast cancer risk has been widely reported, but results were inconsistent and underpowered. To clarify the effects of MTHFR polymorphisms on the risk of breast cancer, an updated meta-analysis of all available studies relating C677T and/or A1298C polymorphisms of MTHFR gene to the risk of breast cancer was conducted....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
